<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="the cells ‘powerhouse’ due to their principal function in synthesizing" exact="adenosine" post="triphosphate (ATP) required for a multitude of processes and"/>
 <result pre="system and its functioning. Oxidative phosphorylation complexes represent reduced nicotinamide" exact="adenine" post="dinucleotide (NADH) dehydrogenase (I), succinate dehydrogenase (II), cytochrome c"/>
 <result pre="phosphorylation complexes represent reduced nicotinamide adenine dinucleotide (NADH) dehydrogenase (I)," exact="succinate" post="dehydrogenase (II), cytochrome c reductase (III), cytochrome c oxidase"/>
 <result pre="eukaryotic-conserved, formation of iron–sulfur clusters and the biosynthesis of haeme," exact="biotin" post="and lipoic acid [15]. More recently, it has emerged"/>
 <result pre="such as tenofovir, which has minimal mitochondrial toxicity compared with" exact="zalcitabine" post="and didanosine [29]. Tenofovir is used in combination with"/>
 <result pre="tenofovir, which has minimal mitochondrial toxicity compared with zalcitabine and" exact="didanosine" post="[29]. Tenofovir is used in combination with other NRTI"/>
 <result pre="is used in combination with other NRTI antivirals such as" exact="abacavir" post="and lamivudine in modern HIV therapy, all of which"/>
 <result pre="in combination with other NRTI antivirals such as abacavir and" exact="lamivudine" post="in modern HIV therapy, all of which report lower"/>
 <result pre="Mechanism Mitochondrial effects Clinical symptoms Antiviral-nuceloside reverse transcriptase inhibitor (NRTI)" exact="Zidovudine" post="(AZT) (black box warning)Acyclovir (ACV)Ganciclovir (GCV)Zalcitabine (ddC) Analogues to"/>
 <result pre="muscle, myopathy [138,139]Neuropathy, liver steacidosis, pancreatitis [29] Antiviral-protease inhibitor (PI)" exact="Saquinavir" post="(black box warning) Inhibits cleavage of host cell polyprotiens"/>
 <result pre="and retinoid signalling [141] Lipodystrophy, hyperlipidaemia, insulin resistance [141] Antibiotic" exact="Tetracycline" post="Inhibition of protein synthesis Decreased mitochondrial membrane potential, down-regulation"/>
 <result pre="membrane potential, down-regulation of ETC function and protein synthesis [67,142]" exact="Ciprofloxacin" post="(black box warning) Inhibition of Top2 (topoisomerase) which prevents"/>
 <result pre="[151] Nephrotoxicity, ototoxicity [152]Peripheral neuropathy [129]Cardiac myopathy [36]Hepatotoxicity [78] Anti-psychotic" exact="Clozapine" post="(black box warning) Binds serotonin and dopamine receptors with"/>
 <result pre="[36]Hepatotoxicity [78] Anti-psychotic Clozapine (black box warning) Binds serotonin and" exact="dopamine" post="receptors with off-target effects on mitochondria [153] Mitochondrial membrane"/>
 <result pre="ATP depletion [49]Oxidation of mitochondrial proteins including malate dehydrogenase and" exact="pyruvate" post="kinase [50,154] Obesity, metabolic disturbances and increased diabetes risk"/>
 <result pre="useful new therapeutic cancer agents such as the common antibiotic" exact="doxycycline" post="with only mild mitochondrial effects [67,68] might have been"/>
 <result pre="reduce oxidative stress-induced damage [78]. The treatments of epilepsy and" exact="pyruvate" post="dehydrogenase (PDH) deficiency are good examples of the therapeutic"/>
 <result pre="metabolic hormesis is demonstrated in Figure 2 where two drugs" exact="bithionol" post="and meclizine are added to Ewings sarcoma cancer cell"/>
 <result pre="function at low drug doses. At each glucose condition tested," exact="bithionol" post="and meclizine at higher doses inhibit oxygen consumption (i.e."/>
 <result pre="2. Oxygen consumption of Ewing sarcoma in the presence of" exact="Bithionol" post="or Meclizine. Ewing sarcoma cell lines TC71 and A673"/>
 <result pre="essential in several tumour types [101,102]. The anticancer BRAF inhibitor" exact="vemurafenib" post="switches cellular metabolism from glycolysis to OXPHOS. This drug,"/>
 <result pre="in tumour progression; therefore, the inhibition of myc proteins through" exact="doxycycline" post="use, or drug-induced modulation of mitochondrial dynamics may have"/>
 <result pre="[100,109]. Antioxidant systems in cells, such as the thioredoxin and" exact="glutathione" post="system, allow cells to cope with excessive ROS production"/>
 <result pre="to apoptosis in cancer cells only. NSC130362, a small molecule" exact="glutathione" post="inhibitor, is one such treatment developed to test this"/>
 <result pre="potential therapeutic benefits of mitochondrial and metabolic manipulation Abbreviations ATP" exact="adenosine" post="triphosphate ETC electron transport chain HIV human immunodeficiency virus"/>
 <result pre="reverse transcriptase inhibitors OXPHOS oxidative phosphorylation PD Parkinson's disease PDH" exact="pyruvate" post="dehydrogenase PRRs pattern recognition receptors RNA ribonucleic acid ROS"/>
 <result pre="PLoS ONE8, e5901210.1371/journal.pone.005901223527073 50BaigM., NavairaE., EscamillaM., RaventosH. and Walss-BassC. (2010)" exact="Clozapine" post="treatment causes oxidation of proteins involved in energy metabolism"/>
 <result pre="L2a modify susceptibility to peripheral neuropathy in Malawian adults on" exact="stavudine" post="containing highly active antiretroviral therapy. J. Acquir. Immune Defic."/>
 <result pre="(2017) Influence of mitochondrial genetics on the mitochondrial toxicity of" exact="linezolid" post="in blood cells and skin nerve fibers. Antimicrob. Agents"/>
 <result pre="Chemother.61, e00542–e0051710.1128/AAC.00542-1728674062 67AhlerE., SullivanW., CassA., BraasD., YorkA., BensingerS.et al. (2013)" exact="Doxycycline" post="alters metabolism and proliferation of human cell lines. PLoS"/>
 <result pre="e6456110.1371/journal.pone.006456123741339 68Son KF.S., IidaT., FurukawaK., FujitaT., YamadaH., ChiaoP.J.et al. (2009)" exact="Doxycycline" post="induces apoptosis in PANC-1 pancreatic cancer cells. Anticancer Res.29,"/>
 <result pre="DahlinM., HallböökT., LindefeldtM., ViggedalG. and DarinN. (2017) Ketogenic diet in" exact="pyruvate" post="dehydrogenase complex deficiency: short- and long-term outcomes. J. Inherit."/>
 <result pre="97AshtonT., FokasE., Kunz-SchughartL., FolkesL., AnbalaganS., HuetherM.et al. (2016) The anti-malarial" exact="atovaquone" post="increases radiosensitivity by alleviating tumour hypoxia. Nat. Commun.710.1038/ncomms12308 98AndrzejewskiS.,"/>
 <result pre="Commun.710.1038/ncomms12308 98AndrzejewskiS., SiegelP. and St-PierreJ. (2018) Metabolic profiles associated with" exact="metformin" post="efficacy in cancer. Front. Endocrinol.9, 37210.3389/fendo.2018.00372 99LeeM., HirparaJ., EuJ.,"/>
 <result pre="high throughput screening reveals a link between TRAIL-mediated apoptosis and" exact="glutathione" post="reductase, a key component of oxidative stress response. PLoS"/>
 <result pre="Fisher-WellmanK., LinC., MaplesJ., CatheyB. and NeuferP. (2013) The anticancer agent" exact="doxorubicin" post="disrupts mitochondrial energy metabolism and redox balance in skeletal"/>
 <result pre="essential for mitochondrial membrane potential change and apoptosis induced by" exact="doxycycline" post="in melanoma cells. Br. J. Pharmacol.160, 1171–118410.1111/j.1476-5381.2010.00746.x20590610 114MohammadH., BarbashO."/>
 <result pre="Ammi-Saı¨dM., FrisdalE., ReyC.et al. (1997) Cellular and mitochondrial toxicity of" exact="zidovudine" post="(AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human"/>
 <result pre="ReyC.et al. (1997) Cellular and mitochondrial toxicity of zidovudine (AZT)," exact="didanosine" post="(ddI) and zalcitabine (ddC) on cultured human muscle cells."/>
 <result pre="Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and" exact="zalcitabine" post="(ddC) on cultured human muscle cells. J. Neurol. Sci.149,"/>
 <result pre="PayneR.M.et al. (1991) Mitochondrial ultrastructural and molecular changes induced by" exact="zidovudine" post="in rat hearts. Lab. Invest.65, 228–2361715447 137Pan-ZhouX., CuiL., ZhouX.,"/>
 <result pre="Rev.37, 1275–129810.1002/med.2145928682452 143HangasA., AasumetsK., KekäläinenN., PaloheinäM., PohjoismäkiJ., GerholdJ.et al. (2018)" exact="Ciprofloxacin" post="impairs mitochondrial DNA replication initiation through inhibition of topoisomerase"/>
 <result pre="Pharmacol.740, 364–37810.1016/j.ejphar.2014.07.02525058905 149TaL., EspesetL., PodratzJ. and WindebankA. (2006) Neurotoxicity of" exact="oxaliplatin" post="and cisplatin for dorsal root ganglion neurons correlates with"/>
 <result pre="149TaL., EspesetL., PodratzJ. and WindebankA. (2006) Neurotoxicity of oxaliplatin and" exact="cisplatin" post="for dorsal root ganglion neurons correlates with platinum-DNA binding."/>
 <result pre="ChiccaM., SimoniE., OlivettoE.et al. (2013) Correlation of adverse effects of" exact="cisplatin" post="administration in patients affected by solid tumours: a retrospective"/>
 <result pre="Psychiatry55, 47–52 PMID:7961573 154Walss-BassC., WeintraubS., HatchJ., MintzJ. and ChaudhuriA. (2008)" exact="Clozapine" post="causes oxidation of proteins involved in energy metabolism: a"/>
 <result pre="BarbosaL., AssisL., GrandiE. and QuevedoJ. (2007) Effect of antipsychotics on" exact="succinate" post="dehydrogenase and cytochrome oxidase activities in rat brain. Naunyn"/>
 <result pre="907–90910.1097/FPC.0b013e32833132cb19741567 159SouzaM., PolizelloA., UyemuraS., Castro-SilvaO. and CurtiC. (1994) Effect of" exact="fluoxetine" post="on rat liver mitochondria. Biochem. Pharmacol.48, 535–54110.1016/0006-2952(94)90283-68068040 160CurtiC., MingattoF.E.,"/>
</results>
